Unchanged angiotensin II-induced release of aldosterone during infusion of prostaglandin E2 in indomethacin-treated healthy subjects. 1982

H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
December 1979, The Journal of clinical investigation,
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
February 1998, Hypertension (Dallas, Tex. : 1979),
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
May 1974, Science (New York, N.Y.),
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
May 2009, Cephalalgia : an international journal of headache,
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
January 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
April 1986, Journal of steroid biochemistry,
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
August 1987, Journal of clinical pharmacology,
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
January 1982, American journal of obstetrics and gynecology,
H Vierhapper, and W Waldhäusl, and J Jörg, and P Nowotny
October 1990, The Italian journal of gastroenterology,
Copied contents to your clipboard!